President John Dramani Mahama has announced that Ghana is set to exit funding support from GAVI, the Vaccine Alliance, by 2030 as the country strengthens its healthcare systems and domestic vaccine financing capacity.
Speaking at the 79th World Health Assembly (WHA) in Geneva on Monday, President Mahama said Ghana’s progress positions it to transition from a beneficiary of international vaccine support to a potential contributor in the near future.
The President also used the platform to highlight the MahamaCares initiative, aimed at making specialised and high-cost medical care accessible to all Ghanaians.
“MahamaCares is ensuring that specialised high-cost care is not a privilege for just a few but a right for all. Ghana, I am also happy to report, is on track to exit GAVI funding for vaccines by the year 2030, and we hope to transition into a donor in the not-too-distant future,” President Mahama told delegates.
GAVI, a global public-private partnership, has supported Ghana’s immunisation programmes for years, providing financing, technical assistance, and vaccines for diseases including measles, polio, pneumococcal infections, rotavirus, yellow fever, and HPV. The support has contributed significantly to improved vaccine coverage and reduced childhood mortality.
Under GAVI’s transition framework, countries that record improvements in their economies and gross national income (GNI) are gradually phased out of donor support and are expected to fully finance their national immunisation programmes.